Ibrahim Yahya, Jamal Shazil, Akhtar Kashif
Royal National Orthopaedic Hospital, London, UK.
Royal London Hospital, London, UK.
J Clin Orthop Trauma. 2021 Apr 1;17:233-238. doi: 10.1016/j.jcot.2021.03.020. eCollection 2021 Jun.
Open fracture management in the United Kingdom and several other countries is guided by the British Orthopaedic Association's Standards for Trauma Number 4 (BOAST-4). This is updated periodically and is based on the best available evidence at the time. The aim of this study is to evaluate the evidence base forming this guidance and to highlight new developments since the last version in 2017.
Searches have been performed using the PubMed, Embase and Medline databases for time periods a) before December 31, 2017 and from 01/01/2018-01/02/2021. Results have been summarized and discussed.
Several contentious issues remain within the 2017 guideline. Antibiotic guidance, the use of antibiotic impregnated PMMA beads and intramedullary devices, irrigation in the emergency department, time to theatre and the use of negative pressure dressings and guidance regarding the management of paediatric injuries have all demonstrated no clear consensus.
The advent of the BOAST-4 guideline has been of huge benefit, however the refinement and improvement of this work remains ongoing. There remains a need for further study into these contentious issues previously listed.
英国和其他几个国家的开放性骨折治疗遵循英国骨科协会创伤标准第4号(BOAST - 4)。该标准会定期更新,且基于当时可获得的最佳证据。本研究的目的是评估形成该指南的证据基础,并突出自2017年上一版以来的新进展。
使用PubMed、Embase和Medline数据库进行检索,检索时间段为a)2017年12月31日之前以及2018年1月1日至2021年2月1日。对结果进行了总结和讨论。
2017年指南中仍存在几个有争议的问题。抗生素指南、抗生素浸渍的聚甲基丙烯酸甲酯(PMMA)珠和髓内装置的使用、急诊科的冲洗、手术时间以及负压敷料的使用,以及关于小儿损伤管理的指南,均未达成明确共识。
BOAST - 4指南的出现带来了巨大益处,然而这项工作仍在不断完善和改进。仍需要对之前列出的这些有争议的问题进行进一步研究。